TY - JOUR
T1 - A benzodiazepine activator locks Kv7.1 channels open by electro-mechanical uncoupling
AU - Schreiber, Julian A.
AU - Möller, Melina
AU - Zaydman, Mark
AU - Zhao, Lu
AU - Beller, Zachary
AU - Becker, Sebastian
AU - Ritter, Nadine
AU - Hou, Panpan
AU - Shi, Jingyi
AU - Silva, Jon
AU - Wrobel, Eva
AU - Strutz-Seebohm, Nathalie
AU - Decher, Niels
AU - Schmitt, Nicole
AU - Meuth, Sven G.
AU - Düfer, Martina
AU - Wünsch, Bernhard
AU - Cui, Jianmin
AU - Seebohm, Guiscard
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Loss-of-function mutations in Kv7.1 often lead to long QT syndrome (LQTS), a cardiac repolarization disorder associated with arrhythmia and subsequent sudden cardiac death. The discovery of agonistic IKs modulators may offer a new potential strategy in pharmacological treatment of this disorder. The benzodiazepine derivative (R)-L3 potently activates Kv7.1 channels and shortens action potential duration, thus may represent a starting point for drug development. However, the molecular mechanisms underlying modulation by (R)-L3 are still unknown. By combining alanine scanning mutagenesis, non-canonical amino acid incorporation, voltage-clamp electrophysiology and fluorometry, and in silico protein modelling, we show that (R)-L3 not only stimulates currents by allosteric modulation of the pore domain but also alters the kinetics independently from the pore domain effects. We identify novel (R)-L3-interacting key residues in the lower S4-segment of Kv7.1 and observed an uncoupling of the outer S4 segment with the inner S5, S6 and selectivity filter segments.
AB - Loss-of-function mutations in Kv7.1 often lead to long QT syndrome (LQTS), a cardiac repolarization disorder associated with arrhythmia and subsequent sudden cardiac death. The discovery of agonistic IKs modulators may offer a new potential strategy in pharmacological treatment of this disorder. The benzodiazepine derivative (R)-L3 potently activates Kv7.1 channels and shortens action potential duration, thus may represent a starting point for drug development. However, the molecular mechanisms underlying modulation by (R)-L3 are still unknown. By combining alanine scanning mutagenesis, non-canonical amino acid incorporation, voltage-clamp electrophysiology and fluorometry, and in silico protein modelling, we show that (R)-L3 not only stimulates currents by allosteric modulation of the pore domain but also alters the kinetics independently from the pore domain effects. We identify novel (R)-L3-interacting key residues in the lower S4-segment of Kv7.1 and observed an uncoupling of the outer S4 segment with the inner S5, S6 and selectivity filter segments.
UR - http://www.scopus.com/inward/record.url?scp=85127456321&partnerID=8YFLogxK
U2 - 10.1038/s42003-022-03229-8
DO - 10.1038/s42003-022-03229-8
M3 - Article
C2 - 35365746
AN - SCOPUS:85127456321
SN - 2399-3642
VL - 5
JO - Communications Biology
JF - Communications Biology
IS - 1
M1 - 301
ER -